Onesource Specialty Pharma Limited — Important, 19-05-2026: Updates
19-05-2026 · 10:55 am
OneSource Specialty Pharma reports annual revenue of Rs 1,421.59 Cr, with a net loss of Rs 73.80 Cr. Operating cash flow turned positive at Rs 8.52 Cr. A significant amalgamation scheme with subsidiaries is under review. A subsidiary faces a major Rs 1,286.22 Cr legal claim, which it disputes.
No comments yet. Be the first to comment!
